ImmunityBio, Inc. IBRX Other current assets
Other current assets at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s other current assets?
- ImmunityBio, Inc. (IBRX) reported other current assets of $3.02M in Q1 2026.
- How has ImmunityBio, Inc.'s other current assets changed year-over-year?
- ImmunityBio, Inc.'s other current assets increased by 28.5% year-over-year, from $2.35M to $3.02M.
- What is the long-term trend for ImmunityBio, Inc.'s other current assets?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s other current assets has grown at a 81.0% compound annual growth rate (CAGR), from $110K to $2.14M.